BCYC - CIK 0001761612
BICYCLE THERAPEUTICS plc (BCYC) reported net income of -$218.96M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$218.96M | -29.5% |
| FY 2024 | -$169.03M | +6.4% |
| FY 2023 | -$180.66M | -60.3% |
| FY 2022 | -$112.72M | -68.7% |
| FY 2021 | -$66.82M | -31.0% |
| FY 2020 | -$51.01M | -66.7% |
| FY 2019 | -$30.61M | -40.1% |
| FY 2018 | -$21.85M | -34.4% |
| FY 2017 |
BICYCLE THERAPEUTICS plc (BCYC) reported net income of -$218.96M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2017 and fiscal 2025, BICYCLE THERAPEUTICS plc's net income declined from -$16.26M to -$218.96M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$16.26M |
| - |